Clinical Trial

Phacovitrectomy Versus Pars Plana Vitrectomy Alone for Post-Intravitreal Injection Endophthalmitis

Completed
View on ClinicalTrials.gov →
Summary
This prospective comparative interventional study evaluated the anatomical and visual outcomes of phacovitrectomy versus pars plana vitrectomy (PPV) alone in patients with post-intravitreal injection endophthalmitis. Eligible patients underwent either combined phacovitrectomy or PPV alone according to the study protocol. The primary outcome was the change in best-corrected visual acuity (BCVA) from baseline to 3 months after surgery. Secondary outcomes included postoperative complications, need for additional surgical intervention, resolution of intraocular inflammation, and restoration of media clarity.
Trial Details
NCT Number NCT07717944
Lead Sponsor Benha University
Conditions Endophthalmitis, Endophthalmitis Postoperative, Intravitreal Injection Patients
Enrollment 40 participants
Start Date 2024-01-15
Primary Completion 2026-06-19 (estimated)
Study Completion 2026-06-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-21